» Articles » PMID: 33052588

Heteromeric Solute Carriers: Function, Structure, Pathology and Pharmacology

Overview
Date 2020 Oct 14
PMID 33052588
Citations 18
Authors
Affiliations
Soon will be listed here.
Abstract

Solute carriers form one of three major superfamilies of membrane transporters in humans, and include uniporters, exchangers and symporters. Following several decades of molecular characterisation, multiple solute carriers that form obligatory heteromers with unrelated subunits are emerging as a distinctive principle of membrane transporter assembly. Here we comprehensively review experimentally established heteromeric solute carriers: SLC3-SLC7 amino acid exchangers, SLC16 monocarboxylate/H symporters and basigin/embigin, SLC4A1 (AE1) and glycophorin A exchanger, SLC51 heteromer Ost α-Ost β uniporter, and SLC6 heteromeric symporters. The review covers the history of the heteromer discovery, transporter physiology, structure, disease associations and pharmacology - all with a focus on the heteromeric assembly. The cellular locations, requirements for complex formation, and the functional role of dimerization are extensively detailed, including analysis of the first complete heteromer structures, the SLC7-SLC3 family transporters LAT1-4F2hc, bAT-rBAT and the SLC6 family heteromer BAT1-ACE2. We present a systematic analysis of the structural and functional aspects of heteromeric solute carriers and conclude with common principles of their functional roles and structural architecture.

Citing Articles

Inhibition of YIPF2 Improves the Vulnerability of Oligodendrocytes to Human Islet Amyloid Polypeptide.

Zhang N, Ma X, He X, Zhang Y, Guo X, Shen Z Neurosci Bull. 2024; 40(10):1403-1420.

PMID: 39078594 PMC: 11422328. DOI: 10.1007/s12264-024-01263-6.


Oligomerization of drug transporters: Forms, functions, and mechanisms.

Ni C, Hong M Acta Pharm Sin B. 2024; 14(5):1924-1938.

PMID: 38799641 PMC: 11119549. DOI: 10.1016/j.apsb.2024.01.007.


The amino acid transporter SLC7A11 expression in breast cancer.

Nath P, Alfarsi L, El-Ansari R, Masisi B, Erkan B, Fakroun A Cancer Biol Ther. 2023; 25(1):2291855.

PMID: 38073087 PMC: 10761065. DOI: 10.1080/15384047.2023.2291855.


Relevance of Sugar Transport across the Cell Membrane.

Carbo R, Rodriguez E Int J Mol Sci. 2023; 24(7).

PMID: 37047055 PMC: 10094530. DOI: 10.3390/ijms24076085.


Systemwide disassembly and assembly of SCF ubiquitin ligase complexes.

Baek K, Scott D, Henneberg L, King M, Mann M, Schulman B Cell. 2023; 186(9):1895-1911.e21.

PMID: 37028429 PMC: 10156175. DOI: 10.1016/j.cell.2023.02.035.


References
1.
Ablack J, Metz P, Chang J, Cantor J, Ginsberg M . Ubiquitylation of CD98 limits cell proliferation and clonal expansion. J Cell Sci. 2015; 128(23):4273-8. PMC: 4712820. DOI: 10.1242/jcs.178129. View

2.
Abplanalp J, Laczko E, Philp N, Neidhardt J, Zuercher J, Braun P . The cataract and glucosuria associated monocarboxylate transporter MCT12 is a new creatine transporter. Hum Mol Genet. 2013; 22(16):3218-26. PMC: 3723308. DOI: 10.1093/hmg/ddt175. View

3.
Abramson J, Wright E . Structure and function of Na(+)-symporters with inverted repeats. Curr Opin Struct Biol. 2009; 19(4):425-32. PMC: 3496787. DOI: 10.1016/j.sbi.2009.06.002. View

4.
Adams J, Broviac M, Brooks W, Johnson N, Issitt P . An antibody, in the serum of a Wr(a+) individual, reacting with an antigen of very high frequency. Transfusion. 1971; 11(5):290-1. DOI: 10.1111/j.1537-2995.1971.tb04416.x. View

5.
Adelman J, Dale A, Zwier M, Bhatt D, Chong L, Zuckerman D . Simulations of the alternating access mechanism of the sodium symporter Mhp1. Biophys J. 2011; 101(10):2399-407. PMC: 3218348. DOI: 10.1016/j.bpj.2011.09.061. View